Dataset Information
Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
Ontology highlight
ABSTRACT:
SUBMITTER: Ontario Health (Quality)
PROVIDER: S-EPMC7143374 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Publications
Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment.
Ontario health technology assessment series 20200306 10
<h4>Background</h4>Breast cancer is a disease in which cells in the breast grow out of control. They often form a tumour that may be seen on an x-ray or felt as a lump.Gene expression profiling (GEP) tests are intended to help predict the risk of metastasis (spread of the cancer to other parts of the body) and to identify people who will most likely benefit from chemotherapy. We conducted a health technology assessment of four GEP tests (EndoPredict, MammaPrint, Oncotype DX, and Prosigna) for pe ...[more]
